Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if oral vancomycin used as primary Clostridium
difficile prophylaxis can reduce the incidence of this infection in high-risk patients.